CVIJIC CHRISTINE MIKAIL (President and CFO) sold 3.7% of their position (4.04K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $84.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/17/2026ACC: 0001543663-26-000007
Officer· President and CFO
Since Feb 2026
-4.04K
Net shares
Net seller
$84.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
4.04K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.39K
Price / share
$20.42
Trade value
$48.75K
% of position
2.2%
3/13/2026
109.84K→107.46K
Common Stock
Direct
Shares
−1.40K
Price / share
$21.25
Trade value
$29.64K
% of position
1.3%
3/13/2026
107.46K→106.06K
Common Stock
Direct
Shares
−263.00
Price / share
$22.02
Trade value
$5.79K
% of position
0.2%
3/13/2026
106.06K→105.80K
Total
Net shares
−4.04K
Net value
-$84.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | S · Sale | −2.39K | $20.42 | $48.75K | 2.2% | 109.84K | 107.46K |
| Common Stock Direct | 3/13/2026 | S · Sale | −1.40K | $21.25 | $29.64K | 1.3% | 107.46K | 106.06K |
| Common Stock Direct | 3/13/2026 | S · Sale | −263.00 | $22.02 | $5.79K | 0.2% | 106.06K | 105.80K |
| Total | −4.04K | -$84.18K | ||||||
Derivative Transactions0
No derivative transactions reported